Cas:50904-38-6 1-Bromo-3-(4-fluorophenoxy)benzene manufacturer & supplier

We serve Chemical Name:1-Bromo-3-(4-fluorophenoxy)benzene CAS:50904-38-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Bromo-3-(4-fluorophenoxy)benzene

Chemical Name:1-Bromo-3-(4-fluorophenoxy)benzene
CAS.NO:50904-38-6
Synonyms:3-Bromophenyl 4-fluorophenyl ether;F-BDE-2;MFCD00142589;Benzene, 1-bromo-3-(4-fluorophenoxy)-;3-Bromo-4′-fluorodiphenyl ether;1-Bromo-3-(4-fluorophenoxy)benzene;3-Bromphenyl-4-fluorphenylether;F-PBDE-2
Molecular Formula:C12H8BrFO
Molecular Weight:267.094
HS Code:2909309090

Physical and Chemical Properties:
Melting point:33-37 °C
Boiling point:299.2±25.0 °C at 760 mmHg
Density:1.5±0.1 g/cm3
Index of Refraction:1.584
PSA:9.23000
Exact Mass:265.974243
LogP:5.40

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3082 9/PG 3
Packing Group:


Contact us for information like 3-Bromophenyl 4-fluorophenyl ether chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,F-PBDE-2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,1-Bromo-3-(4-fluorophenoxy)benzene Use and application,MFCD00142589 technical grade,usp/ep/jp grade.


Related News: The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan. 1-Bromo-3-(4-fluorophenoxy)benzene manufacturer The company reported that it was cooperating with the Justice Department probe and that an outside law firm was also “investigating these allegations thoroughly.” 1-Bromo-3-(4-fluorophenoxy)benzene supplier The Branchburg factory first came under FDA scrutiny in late 2019, when agency inspectors began to document numerous quality control problems. By March, 2020, the FDA had deemed the manufacturing issues as “Official Action Indicated,” its most serious category of violation. 1-Bromo-3-(4-fluorophenoxy)benzene vendor Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS. 1-Bromo-3-(4-fluorophenoxy)benzene factory The government will also send a charter flight with an Air New Zealand crew to repatriate up to 300 citizens in Wuhan.